452 related articles for article (PubMed ID: 33921642)
1. Early Life Stress and Risks for Opioid Misuse: Review of Data Supporting Neurobiological Underpinnings.
Oswald LM; Dunn KE; Seminowicz DA; Storr CL
J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33921642
[TBL] [Abstract][Full Text] [Related]
2. Effects of prenatal opioid exposure on synaptic adaptations and behaviors across development.
Simmons SC; Grecco GG; Atwood BK; Nugent FS
Neuropharmacology; 2023 Jan; 222():109312. PubMed ID: 36334764
[TBL] [Abstract][Full Text] [Related]
3. Mental health and substance use disorder comorbidities among Medicaid beneficiaries: Associations with opioid use disorder and prescription opioid misuse.
Swartz JA; Franceschini D; Scamperle K
AIMS Public Health; 2023; 10(3):658-677. PubMed ID: 37842281
[TBL] [Abstract][Full Text] [Related]
4. The failing cascade: Comorbid post traumatic stress- and opioid use disorders.
Elman I; Borsook D
Neurosci Biobehav Rev; 2019 Aug; 103():374-383. PubMed ID: 31063739
[TBL] [Abstract][Full Text] [Related]
5. Can the type of subjective response to first opioid exposure predict the risk of opioid use disorder? A scoping review.
Morris CJ; Mills-Huffnagle S; Zgierska AE
Brain Res Bull; 2022 Oct; 188():67-76. PubMed ID: 35901984
[TBL] [Abstract][Full Text] [Related]
6. Early Life Stress as a Predictor of Co-Occurring Alcohol Use Disorder and Post-Traumatic Stress Disorder.
Lee RS; Oswald LM; Wand GS
Alcohol Res; 2018; 39(2):147-159. PubMed ID: 31198654
[TBL] [Abstract][Full Text] [Related]
7. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
[TBL] [Abstract][Full Text] [Related]
8. Moderators for the Relationship between Post-Traumatic Stress Disorder and Opioid Use Disorder.
Tasmim S; Le Foll B; Hassan AN
J Dual Diagn; 2022; 18(1):3-10. PubMed ID: 34982654
[No Abstract] [Full Text] [Related]
9. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
[TBL] [Abstract][Full Text] [Related]
10. Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?
Gold MS; Baron D; Bowirrat A; Blum K
J Neurol Sci; 2020 Nov; 418():117137. PubMed ID: 32957037
[TBL] [Abstract][Full Text] [Related]
11. Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?
Gondré-Lewis MC; Elman I; Alim T; Chapman E; Settles-Reaves B; Galvao C; Gold MS; Baron D; Kazmi S; Gardner E; Gupta A; Dennen C; Blum K
Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453620
[TBL] [Abstract][Full Text] [Related]
12. Associations Between the Specialty of Opioid Prescribers and Opioid Addiction, Misuse, and Overdose Outcomes.
Lobo CP; Cochran G; Chang CH; Gellad WF; Gordon AJ; Jalal H; Lo-Ciganic WH; Karp JF; Kelley D; Donohue JM
Pain Med; 2020 Sep; 21(9):1871-1890. PubMed ID: 31626295
[TBL] [Abstract][Full Text] [Related]
13. Endogenous opioid systems alterations in pain and opioid use disorder.
Higginbotham JA; Markovic T; Massaly N; Morón JA
Front Syst Neurosci; 2022; 16():1014768. PubMed ID: 36341476
[TBL] [Abstract][Full Text] [Related]
14. Early life stress and substance use disorders: The critical role of adolescent substance use.
Kirsch DE; Lippard ETC
Pharmacol Biochem Behav; 2022 Apr; 215():173360. PubMed ID: 35219756
[TBL] [Abstract][Full Text] [Related]
15. [Neurobiology of early life traumatic stress and trauma: Prolonged neuroendocrine dysregulation as a neurodevelopmental risk factor].
Gkesoglou T; Pervanidou P; Bozikas VP; Agorastos A
Psychiatriki; 2023 Jul; 34(2):122-132. PubMed ID: 35255464
[TBL] [Abstract][Full Text] [Related]
16. Opioid use disorder in cancer patients.
Lewis CES; Schutzer-Weissmann J; Farquhar-Smith P
Curr Opin Support Palliat Care; 2023 Jun; 17(2):98-103. PubMed ID: 36866646
[TBL] [Abstract][Full Text] [Related]
17. Prescription opioid misuse among adolescents and emerging adults in the United States: A scoping review.
Bonar EE; Coughlin L; Roche JS; Philyaw-Kotov ML; Bixler EA; Sinelnikov S; Kolosh A; Cihak MJ; Cunningham RM; Walton MA
Prev Med; 2020 Mar; 132():105972. PubMed ID: 31904397
[TBL] [Abstract][Full Text] [Related]
18. Adults who misuse opioids: Substance abuse treatment use and perceived treatment need.
Choi NG; DiNitto DM; Marti CN; Choi BY
Subst Abus; 2019; 40(2):247-255. PubMed ID: 30810503
[No Abstract] [Full Text] [Related]
19. A review of nonhuman primate models of early life stress and adolescent drug abuse.
Wakeford AGP; Morin EL; Bramlett SN; Howell LL; Sanchez MM
Neurobiol Stress; 2018 Nov; 9():188-198. PubMed ID: 30450384
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
